Kalm Therapeutics (Kalm Tx) is pleased to announce the appointment of Dr. Tomoko Maeda-Chubachi, M.D., Ph.D., as our Chief ...

Can Kamala Harris beat Donald Trump? Latest poll updates The world’s TASTIEST potato dishes ranked A boomer couple who have pensions after working their whole lives said they're just scraping by ...

Selling plaque psoriasis drug Vtama to Organon looks like another win for Roivant, which has been buying overlooked drugs, ...

Here we encounter businesses such as: Unilever (ULVR): The maker of everything from ice cream to soap to Bovril ... Haleon ...

In Bakery division, the company launched two new products, namely Chapi and Cream Rolls ... a Scheme of Amalgamation between the Company and GlaxoSmithKline Consumer Healthcare Limited (GSK ...

The drug was the lead molecule in GSK's immuno-inflammation pipeline back ... compared to 6% of a placebo cream group. "Our participation in the revenue sale transaction reflects our confidence ...

It's also known for its prolific use of mergers and acquisitions; the company is in the process of spinning of its ice cream business ... The Motley Fool recommends GSK, Philip Morris ...

While at GSK, Dr. Maeda-Chubachi was responsible for leading the Phase II clinical trial of eczema/psoriasis topical cream, Vtama. The clinical trial design and results led to the acquisition of ...

Among private dairies in India, the company’s well-known brands Arun, Arokya, and Hatsun are leaders in the ice cream, milk, and curd categories ... (FICCI), Tamil Nadu State Council, is Dr. GSK Velu, ...

with a standardized daily regimen of low-potency TCS (hydrocortisone acetate 1% cream). In-clinic visits were planned at baseline, week 1, week 2, and week 4, then monthly through week 16, with weekly ...